MJM-31973-05994 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-01
Dose 1 — Pfizer-BioNTech
2021-06-13
Registered in v-safe
2021-06-13
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-06-22
Dose 2 — Pfizer-BioNTech
2021-06-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-06-29
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-07-06
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-07-13
Survey response — day 21, dose 2
MedDRA: Headache, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair

Free text: Headache, runny nose, stuffy, sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-08-03
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-12-21
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-01	Pfizer-BioNTech
2	2021-06-22	Pfizer-BioNTech	No

Free text

Release 9 — day 21, dose 2

2021-07-13

Symptoms: Headache, runny nose, stuffy, sore throat

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	✓	✓	✓
SD	Nasal congestion	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Rhinorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release